Mirabegron Clonmel 50 mg prolonged-release tablets

Licence status
Authorised: 06/09/2024
Active substances
Mirabegron
Dosage Form
Prolonged-release tablet
Licence number
PA0126/396/001
Licence holder
Clonmel Healthcare Ltd

Product documents

Licence information

ATC code
G04BD12 mirabegron
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
06/09/2024